The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kellen Scott since 2013.
This trader's CIK number is 1490476.
At the time of last reporting, Kellen Scott was the CFO and Secretary of Diamedica Therapeutics Inc.. (stock ticker symbol DMAC).
Also see all insider trading activities at Diamedica Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | DMAC | 10,000 | $39,100 | 0 | $0 | 0 | $0 |
| 2021 | DMAC | 10,000 | $31,460 | 0 | $0 | 0 | $0 |
| 2020 | DMAC | 2,000 | $8,386 | 0 | $0 | 0 | $0 |
| 2019 | DMAC | 7,000 | $19,062 | 0 | $0 | 0 | $0 |
| 2018 | DMAC | 1,250 | $5,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | SNBP | 35,000 | $0 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | KIPS | 20,000 | $15,950 | 0 | $0 | 0 | $0 |
1. Diamedica Therapeutics Inc. (DMAC)
2. Panbela Therapeutics, Inc. (SNBP)
3. Kips Bay Medical, Inc. (KIPS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-23 | DMAC | Buy | 10,000 | 3.91 | 39,100 |
| 2021-08-16 | DMAC | Buy | 10,000 | 3.15 | 31,460 |
| 2020-11-09 | DMAC | Buy | 2,000 | 4.19 | 8,386 |
| 2019-08-19 | DMAC | Buy | 3,000 | 2.43 | 7,290 |
| 2019-05-24 | DMAC | Buy | 4,000 | 2.94 | 11,772 |
| 2018-12-11 | DMAC | Buy | 1,250 | 4.00 | 5,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-06-24 | SNBP | Buy | 35,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-08-30 | KIPS | Buy | 10,000 | .78 | 7,750 |
| 2013-08-12 | KIPS | Buy | 10,000 | .82 | 8,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kellen Scott (CFO and Secretary of Diamedica Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.